Cardiac Arrhythmias and Covid-19
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | International Journal of Cardiovascular Sciences (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201 |
Resumo: | Abstract Cardiovascular manifestations of COVID-19 include cardiac rhythm disturbances, whose mechanisms, incidence, and most common types are not well established in this population. Intense inflammatory response and metabolic activity contribute to recurrence of pre-existing arrhythmias, and other arrhythmias can occur due to myocardial injury, acute coronary insufficiency, and electrolyte disturbances. Brady- and tachyarrhythmias, as well as conduction disorders have been described. QT interval prolongation and fatal ventricular arrhythmias ( Torsades de Pointes ) may result from the pathological process or adverse effect of drugs (antiarrhythmics, chloroquine / hydroxychloroquine, azithromycin and antivirals). Patients with congenital heart disease and hemodynamic repercussions, patients with signs of heart failure, pulmonary hypertension, cyanosis, hypoxemia, and those who underwent heart transplantation and immunosuppression are at greater risk. In patients with implantable cardioverter-defibrillators (ICDs), the risk depends on the presence of structural heart disease. In the course of COVID-19, in-person assessment of these patients should be limited to high-risk situations, including syncope, worsening of heart failure and shock delivery by ICDs. Likewise, cardiac implantable electronic device implantation or replacement surgery should be limited to emergency and urgent cases, including symptomatic high-degree atrioventricular block, ICD for secondary prevention and pulse generator replacement due to battery drain. |
id |
SBC-2_a5313195719e8cb78de1979ec75066b9 |
---|---|
oai_identifier_str |
oai:scielo:S2359-56472021005012201 |
network_acronym_str |
SBC-2 |
network_name_str |
International Journal of Cardiovascular Sciences (Online) |
repository_id_str |
|
spelling |
Cardiac Arrhythmias and Covid-19Coronavirus InfectionsCardiac ArrhythmiasArtificial PacemakerAbstract Cardiovascular manifestations of COVID-19 include cardiac rhythm disturbances, whose mechanisms, incidence, and most common types are not well established in this population. Intense inflammatory response and metabolic activity contribute to recurrence of pre-existing arrhythmias, and other arrhythmias can occur due to myocardial injury, acute coronary insufficiency, and electrolyte disturbances. Brady- and tachyarrhythmias, as well as conduction disorders have been described. QT interval prolongation and fatal ventricular arrhythmias ( Torsades de Pointes ) may result from the pathological process or adverse effect of drugs (antiarrhythmics, chloroquine / hydroxychloroquine, azithromycin and antivirals). Patients with congenital heart disease and hemodynamic repercussions, patients with signs of heart failure, pulmonary hypertension, cyanosis, hypoxemia, and those who underwent heart transplantation and immunosuppression are at greater risk. In patients with implantable cardioverter-defibrillators (ICDs), the risk depends on the presence of structural heart disease. In the course of COVID-19, in-person assessment of these patients should be limited to high-risk situations, including syncope, worsening of heart failure and shock delivery by ICDs. Likewise, cardiac implantable electronic device implantation or replacement surgery should be limited to emergency and urgent cases, including symptomatic high-degree atrioventricular block, ICD for secondary prevention and pulse generator replacement due to battery drain.Sociedade Brasileira de Cardiologia2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201International Journal of Cardiovascular Sciences n.ahead 2021reponame:International Journal of Cardiovascular Sciences (Online)instname:Sociedade Brasileira de Cardiologia (SBC)instacron:SBC10.36660/ijcs.20200123info:eu-repo/semantics/openAccessFagundes,Alexsandro AlvesMelo,Sissy Lara deArmaganijan,LucianaKuniyoshi,RicardoMoraes,Luis Gustavo Belo deBorges,Vanessa Alves GuimarãesScanavacca,MauricioMartinelli Filho,MartinoTeixeira,Ricardo Alkmimeng2021-09-01T00:00:00Zoai:scielo:S2359-56472021005012201Revistahttp://publicacoes.cardiol.br/portal/ijcshttps://old.scielo.br/oai/scielo-oai.phptailanerodrigues@cardiol.br||revistaijcs@cardiol.br2359-56472359-4802opendoar:2021-09-01T00:00International Journal of Cardiovascular Sciences (Online) - Sociedade Brasileira de Cardiologia (SBC)false |
dc.title.none.fl_str_mv |
Cardiac Arrhythmias and Covid-19 |
title |
Cardiac Arrhythmias and Covid-19 |
spellingShingle |
Cardiac Arrhythmias and Covid-19 Fagundes,Alexsandro Alves Coronavirus Infections Cardiac Arrhythmias Artificial Pacemaker |
title_short |
Cardiac Arrhythmias and Covid-19 |
title_full |
Cardiac Arrhythmias and Covid-19 |
title_fullStr |
Cardiac Arrhythmias and Covid-19 |
title_full_unstemmed |
Cardiac Arrhythmias and Covid-19 |
title_sort |
Cardiac Arrhythmias and Covid-19 |
author |
Fagundes,Alexsandro Alves |
author_facet |
Fagundes,Alexsandro Alves Melo,Sissy Lara de Armaganijan,Luciana Kuniyoshi,Ricardo Moraes,Luis Gustavo Belo de Borges,Vanessa Alves Guimarães Scanavacca,Mauricio Martinelli Filho,Martino Teixeira,Ricardo Alkmim |
author_role |
author |
author2 |
Melo,Sissy Lara de Armaganijan,Luciana Kuniyoshi,Ricardo Moraes,Luis Gustavo Belo de Borges,Vanessa Alves Guimarães Scanavacca,Mauricio Martinelli Filho,Martino Teixeira,Ricardo Alkmim |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Fagundes,Alexsandro Alves Melo,Sissy Lara de Armaganijan,Luciana Kuniyoshi,Ricardo Moraes,Luis Gustavo Belo de Borges,Vanessa Alves Guimarães Scanavacca,Mauricio Martinelli Filho,Martino Teixeira,Ricardo Alkmim |
dc.subject.por.fl_str_mv |
Coronavirus Infections Cardiac Arrhythmias Artificial Pacemaker |
topic |
Coronavirus Infections Cardiac Arrhythmias Artificial Pacemaker |
description |
Abstract Cardiovascular manifestations of COVID-19 include cardiac rhythm disturbances, whose mechanisms, incidence, and most common types are not well established in this population. Intense inflammatory response and metabolic activity contribute to recurrence of pre-existing arrhythmias, and other arrhythmias can occur due to myocardial injury, acute coronary insufficiency, and electrolyte disturbances. Brady- and tachyarrhythmias, as well as conduction disorders have been described. QT interval prolongation and fatal ventricular arrhythmias ( Torsades de Pointes ) may result from the pathological process or adverse effect of drugs (antiarrhythmics, chloroquine / hydroxychloroquine, azithromycin and antivirals). Patients with congenital heart disease and hemodynamic repercussions, patients with signs of heart failure, pulmonary hypertension, cyanosis, hypoxemia, and those who underwent heart transplantation and immunosuppression are at greater risk. In patients with implantable cardioverter-defibrillators (ICDs), the risk depends on the presence of structural heart disease. In the course of COVID-19, in-person assessment of these patients should be limited to high-risk situations, including syncope, worsening of heart failure and shock delivery by ICDs. Likewise, cardiac implantable electronic device implantation or replacement surgery should be limited to emergency and urgent cases, including symptomatic high-degree atrioventricular block, ICD for secondary prevention and pulse generator replacement due to battery drain. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.36660/ijcs.20200123 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Cardiologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Cardiologia |
dc.source.none.fl_str_mv |
International Journal of Cardiovascular Sciences n.ahead 2021 reponame:International Journal of Cardiovascular Sciences (Online) instname:Sociedade Brasileira de Cardiologia (SBC) instacron:SBC |
instname_str |
Sociedade Brasileira de Cardiologia (SBC) |
instacron_str |
SBC |
institution |
SBC |
reponame_str |
International Journal of Cardiovascular Sciences (Online) |
collection |
International Journal of Cardiovascular Sciences (Online) |
repository.name.fl_str_mv |
International Journal of Cardiovascular Sciences (Online) - Sociedade Brasileira de Cardiologia (SBC) |
repository.mail.fl_str_mv |
tailanerodrigues@cardiol.br||revistaijcs@cardiol.br |
_version_ |
1754732627440435200 |